ArticleThe oncologist2025

Clinical utility of companion diagnostic biomarker results below the limit of detection in comprehensive genomic profiling of patients with advanced non-small cell lung cancer.

Gerald Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.